Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,268
Ph III recruiting: 131
Growth YoY: +6.7%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,373)

clinicaltrialsPublishedShowing 801–803 of 803 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00078598	A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma	unknown	Phase 3	506	Corixa CorporationINDUSTRY	1	Nov 9, 2005	clinicaltrials
NCT00140569	Randomized Study for Patients With Follicular Lymphoma Needing Treatment	completed	Phase 3	400	Lymphoma Study AssociationOTHER	2	Sep 1, 2005	clinicaltrials